Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.640
+0.120 (3.41%)
Jan 22, 2026, 2:34 PM EST - Market open
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $284.38 million as of January 22, 2026. Its market cap has decreased by -4.35% in one year.
Market Cap
284.38M
Enterprise Value
-49.74M
1-Year Change
-4.35%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $284.38M, a decrease of -85.32%. That is a compound annual growth rate of -30.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 275.01M | -1.40% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 284.16M |
| Fractyl Health | 283.74M |
| Neurogene | 283.62M |
| Shattuck Labs | 280.96M |
| Rezolute | 280.04M |
| Relmada Therapeutics | 279.40M |
| Nautilus Biotechnology | 275.35M |
| Silence Therapeutics | 268.29M |